GSK983

Modify Date: 2024-11-27 21:08:03

GSK983 Structure
GSK983 structure
Common Name GSK983
CAS Number 827591-02-6 Molecular Weight 325.79200
Density N/A Boiling Point N/A
Molecular Formula C18H16ClN3O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of GSK983


GSK983 is a broad-spectrum antiviral agent. GSK983 inhibits the replication of adenovirus-5 (Ad-5) and polyoma virus SV40. GSK983 inhibits the growth of cell lines immortalized by EBV, HTLV1, HPV. GSK983 induces the expression of interferon-stimulated genes[1].

 Names

Name N-[(1R)-6-chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl]pyridine-2-carboxamide
Synonym More Synonyms

 GSK983 Biological Activity

Description GSK983 is a broad-spectrum antiviral agent. GSK983 inhibits the replication of adenovirus-5 (Ad-5) and polyoma virus SV40. GSK983 inhibits the growth of cell lines immortalized by EBV, HTLV1, HPV. GSK983 induces the expression of interferon-stimulated genes[1].
Related Catalog
In Vitro GSK983 (0-10000 nM; 2 h) 抑制原代人成纤维细胞 (HFF) 中腺病毒 5 (Ad-5) 和 Vero 细胞中多瘤病毒 SV40 的复制,中值效应浓度 (K) 分别为 21 nM、7.5 nM; 最大抑制率 (I max) 分别为 99%、88%[1]。 GSK983 (0-10000 nM; 72 h) 抑制通过病毒感染永生化的细胞系的生长,对 IM9 (EBV),B-LCL 5/2/1 ( EBV), MT4 (HTLV1) 细胞的中值效应浓度 (K) 分别为 16, 14, 7.5 nM[1]. GSK983 (10, 100 nM; 24, 48 h) 在 W12, HKC 细胞中诱导干扰素刺激基因的表达[1]。 RT-PCR[1] Cell Line: W12, HKC cells Concentration: 10, 100 nM Incubation Time: 24, 48 h Result: Induced the expression of interferon-stimulated genes in infected and immortalized cells, increased the gene expression of CSF2, IFIT1 (ISG56), IL6, ISG15, OAS1, OAS2, OASL and TNFSF10 (TRAIL).
References

[1]. Harvey R,et al. GSK983: a novel compound with broad-spectrum antiviral activity. Antiviral Res. 2009 Apr;82(1):1-11.  

 Chemical & Physical Properties

Molecular Formula C18H16ClN3O
Molecular Weight 325.79200
Exact Mass 325.09800
PSA 61.27000
LogP 4.59850

 Synonyms

gsk983
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.